Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governorate.

@article{AboMadyan2004ClinicalTO,
  title={Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governorate.},
  author={Ahmed A Abo-Madyan and Tosson Aly Morsy and Saad M Motawea and Ayman Tosson Aly Morsy},
  journal={Journal of the Egyptian Society of Parasitology},
  year={2004},
  volume={34 3},
  pages={807-18}
}
A field survey was done in Ezbet El-Bakly, Al-Fayoum Governorate, Egypt to assess the efficacy and safety of Mirazid in the treatment of human fascioliasis. Among 1019 individuals examined for parasitosis, the prevalence of fascioliasis was 1.7% and the geometric mean egg count (GMEC) was 33.2 eggs/gram stools. About 23.5% of the fascioliasis patients were asymptomatic. The most frequent symptoms were abdominal dis\tension and flatulence (76.5%), right hypochondrial pain (17.6%) and epigastric… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Parasitic Infections: Is Male and Female Difference for Anemia and Growth Retardation Evident?

Journal of the Egyptian Society of Parasitology • 2015
View 2 Excerpts
Highly Influenced

Repurposing drugs for the treatment and control of helminth infections

International journal for parasitology. Drugs and drug resistance • 2014
View 2 Excerpts

Similar Papers

Loading similar papers…